Nanalysis Scientific Corp.
NSCI.V
TSX
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | -5.32M | -1.21M | -1.46M | -1.87M | -1.99M |
Total Depreciation and Amortization | 325.80K | 347.50K | 344.90K | 356.80K | -1.15M |
Total Amortization of Deferred Charges | 499.30K | 506.60K | 498.40K | 497.70K | 1.95M |
Total Other Non-Cash Items | 5.79M | 689.20K | 765.90K | 666.10K | 740.20K |
Change in Net Operating Assets | -530.80K | -574.80K | 619.70K | 1.44M | -1.42M |
Cash from Operations | 762.20K | -236.80K | 771.00K | 1.09M | -1.88M |
Capital Expenditure | 0.00 | -4.40K | -700.00 | -36.30K | -81.60K |
Sale of Property, Plant, and Equipment | 77.20K | 18.30K | 25.60K | -- | -700.00 |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | 0.00 |
Other Investing Activities | -249.30K | -310.90K | -365.40K | -392.40K | -805.60K |
Cash from Investing | -172.20K | -296.90K | -340.60K | -428.70K | -887.90K |
Total Debt Issued | 1.61M | 1.19M | -- | -- | 3.67M |
Total Debt Repaid | -1.06M | -1.09M | -859.00K | -3.95M | 557.00K |
Issuance of Common Stock | 0.00 | -- | 0.00 | 4.36M | 0.00 |
Repurchase of Common Stock | -- | -20.00K | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -222.00K | -252.00K | -298.00K | -354.00K | -982.00K |
Cash from Financing | 233.60K | -128.30K | -845.50K | 36.30K | 2.39M |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 823.70K | -662.10K | -415.10K | 693.50K | -376.30K |